AKBA logo

Akebia Therapeutics (AKBA) CAPEX

Annual CAPEX

N/A

31 December 2023

AKBA CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CAPEX

$2000.00
-$27.00 K-93.10%

30 September 2024

AKBA Quarterly CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CAPEX

$31.00 K
+$2000.00+6.90%

30 September 2024

AKBA TTM CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

AKBA CAPEX Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years-+100.0%-91.8%
5 y5 years--99.9%-99.6%

AKBA CAPEX High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-98.3%-91.8%+6.9%
5 y5 years-99.9%+104.4%-99.6%+6.9%
alltimeall time-99.9%+104.4%-99.6%+6.9%

Akebia Therapeutics CAPEX History

DateAnnualQuarterlyTTM
Sept 2024
-
$2000.00(-93.1%)
$31.00 K(+6.9%)
June 2024
-
$29.00 K(>+9900.0%)
$29.00 K(-74.6%)
Dec 2022
$114.00 K(+93.2%)
$0.00(0.0%)
$114.00 K(0.0%)
Sept 2022
-
$0.00(0.0%)
$114.00 K(0.0%)
June 2022
-
$0.00(-100.0%)
$114.00 K(0.0%)
Mar 2022
-
$114.00 K(>+9900.0%)
$114.00 K(+93.2%)
Dec 2021
$59.00 K(-81.4%)
$0.00(0.0%)
$59.00 K(-84.3%)
Sept 2021
-
$0.00(0.0%)
$376.00 K(+13.6%)
June 2021
-
$0.00(-100.0%)
$331.00 K(-12.0%)
Mar 2021
-
$59.00 K(-81.4%)
$376.00 K(+18.6%)
Dec 2020
$317.00 K(-95.2%)
$317.00 K(-804.4%)
$317.00 K(+44.1%)
Sept 2020
-
-$45.00 K(-200.0%)
$220.00 K(-92.1%)
June 2020
-
$45.00 K(-79.5%)
$2.79 M(-58.0%)
DateAnnualQuarterlyTTM
Dec 2019
$6.66 M(+314.4%)
$220.00 K(-91.3%)
$6.66 M(-8.4%)
Sept 2019
-
$2.53 M(+27.9%)
$7.26 M(+44.1%)
June 2019
-
$1.98 M(+2.6%)
$5.04 M(+55.7%)
Mar 2019
-
$1.93 M(+132.3%)
$3.24 M(+101.6%)
Dec 2018
$1.61 M(-1.0%)
$830.00 K(+170.4%)
$1.61 M(+31.0%)
Sept 2018
-
$307.00 K(+77.5%)
$1.23 M(-19.1%)
June 2018
-
$173.00 K(-41.6%)
$1.52 M(+1.7%)
Mar 2018
-
$296.00 K(-34.2%)
$1.49 M(-8.1%)
Dec 2017
$1.62 M(-39.1%)
$450.00 K(-24.6%)
$1.62 M(+33.0%)
Sept 2017
-
$597.00 K(+303.4%)
$1.22 M(+95.8%)
June 2017
-
$148.00 K(-65.3%)
$623.00 K(+31.2%)
Mar 2017
-
$427.00 K(+789.6%)
$475.00 K(+889.6%)
Dec 2016
$2.66 M
$48.00 K
$48.00 K

FAQ

  • What is the all time high annual CAPEX for Akebia Therapeutics?
  • What is Akebia Therapeutics quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Akebia Therapeutics?
  • What is Akebia Therapeutics TTM capital expenditures?
  • What is the all time high TTM CAPEX for Akebia Therapeutics?

What is the all time high annual CAPEX for Akebia Therapeutics?

Akebia Therapeutics all-time high annual capital expenditures is $6.66 M

What is Akebia Therapeutics quarterly capital expenditures?

The current quarterly CAPEX of AKBA is $2000.00

What is the all time high quarterly CAPEX for Akebia Therapeutics?

Akebia Therapeutics all-time high quarterly capital expenditures is $2.53 M

What is Akebia Therapeutics TTM capital expenditures?

The current TTM CAPEX of AKBA is $31.00 K

What is the all time high TTM CAPEX for Akebia Therapeutics?

Akebia Therapeutics all-time high TTM capital expenditures is $7.26 M